Gain Therapeutics, Inc.
USD1.83
-0.13 (-6.63%)
CEO
Gene Mack
IPO Date
2021-03-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.91
Prev. Close
$1.96
Day Low
$1.82
Day High
$1.92
52W Low
$1.41
52W High
$4.34
Market Cap
$0.08B
Volume
0.89M
| 50,000 |
| $1.86 |
| 25 Jun 2025 | Islam Khalid | director | A-Award | Acquired | 15,000 | $1.79 |
| 25 Jun 2025 | Nicaise Claude | director | A-Award | Acquired | 15,000 | $1.79 |
| 25 Jun 2025 | Riley Jeffrey Scott | director | A-Award | Acquired | 15,000 | $1.79 |
| 25 Jun 2025 | RICHMAN ERIC I | director | A-Award | Acquired | 15,000 | $1.79 |
| 25 Jun 2025 | HASLER HANS PETER | director | A-Award | Acquired | 15,000 | $1.79 |
| 25 Jun 2025 | GOLDSTEIN DOV A MD | director | A-Award | Acquired | 15,000 | $1.79 |
| 25 Jun 2025 | Melincoff Gwen A | director | A-Award | Acquired | 15,000 | $1.79 |
| 21 Mar 2025 | Mack Gene | director, officer: CEO, President | A-Award | Acquired | 200,000 | $2.29 |